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Distal intracoronary infusion of the perfluorochemical Flu·
osol·DA 20% has been shown to prevent systolic dysfunc·
tion during coronary artery balloon occlusion in coronary
angioplasty. To assess its effect on global diastolic dysfunc·
tion, a randomized, single·blind, crossover protocol com·
paring intracoronary infusion of Fluosol or no infusion
(control) was performed during 60 s balloon inflations in 10
patients (mean age 67 years) undergoing coronary angio-
plasty. Assessment of global systolic and diastolic function
was obtained with high fidelity micromanometer measure·
ments of left ventricular pressure. Eighteen pairs of balloon
inflations (Fluosol versus control) were analyzed.
Patients reported significantly less severe chest pain
during inflations accompanied by Fluosol compared with
control. However, during coronary balloon occlusion, no
significant differences in the changes from baseline values
were observed between Fluosol and control with regard to
The consequences of balloon inflation during percutaneous
transluminal coronary angioplasty on left ventricular func-
tion have been well described and include significant depres-
sion in both systolic and diastolic function (1-5). These
changes are usually reversible after balloon deflation. al-
though in patients with preexisting left ventricular dysfunc-
tion. prolonged hemodynamic deterioration may follow. If
an effective means of myocardial protection could be em-
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ventricular relaxation, including the time constant of early
ventricular relaxation (tau) and maximal rate of fall in left
ventricular pressure (maximal negative dP/dt). No differ·
ences between Fluosol and control were observed in terms
of the increase in end·diastolic pressure or minimal dias·
tolic pressure during balloon inflation. Mean systolic pres·
sure decrease from baseline values was greater during
control than during Fluosol inflations (-9.0 ± 3.3 mm Hg,
p =0.013), but no significant difference was observed in the
change in maximal rate of rise in left ventricular pressure
(maximal positive dP/dt).
These results suggest that Fluosol does not preserve
global left ventricular diastolic function during coronary
balloon occlusion, possibly because of its limited oxygen
delivery capability relative to arterial blood.
(J Am Coli Cardiol1990;16:959-66)
ployed during balloon inflation. prolonged balloon inflations
might be possible. which may improve initial angiographic
results (6) and aid in managing acute complications of the
procedure such as coronary dissection. It could also enhance
the overall safety and comfort of coronary angioplasty and
permit its wider use in high risk patients.
One approach to myocardial protection during coronary
angioplasty has been to infuse the oxygenated perfiuoro-
chemical Fluosol-DA 20% through the lumen of the dilating
balloon catheter. Distal coronary infusion of Fluosol during
angioplasty appears to reduce ischemia (7) and ameliorate
left ventricular systolic dysfunction as assessed by echocar-
diography (8.9).
Global diastolic dysfunction is a sensitive marker of
myocardial ischemia and occurs earlier than global systolic
dysfunction (10-12). Because this observation has also been
noted during coronary angioplasty (1), we hypothesized that
Fluosol. if effective in 'preventing ischemia. should prevent
0735-1097/90/$3.50
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Table 1. Clinical and Angiographic Characteristics of 10 Patients
Technique and medication. Coronary angioplasty was
performed using Profile-Plus balloon catheters (USCI Divi-
sion, C. R. Bard) inserted through the right femoral artery
using standard techniques. Attempts to use a Mini-Profile
balloon catheter (USC!) in one patient and The Skinny
(SciMed) in another failed as a result of catheter rupture
during Fluosol infusion. Before the procedure, all patients
received 325 mg of aspirin. All but two patients were
receiving a calcium channel antagonist at the time of angio-
plasty, two patients were treated with an oral long-acting
nitrate, one with a beta-adrenergic blocking agent and two
patients were receiving no regular medication. All patients
were given sublingual nitroglycerin in the catheterization
laboratory before angioplasty and received 10,000 to 15,000
U of intravenous heparin.
The Fluosol was thawed before the study, warmed to
37°C in a water bath and bubble-oxygenated for 30 to 60 min.
The mean (±SD) of the partial pressure of oxygen (Poz) of
the Fluosol measured within 30 min of initiation of the
infusion was 685 ± 57 mm Hg (range 613 to 776). Before the
procedure, each patient received a 0.5 ml intravenous test
dose of Fluosol. The infusate was maintained at body
temperature until immediately before use and infused
through the distal port of the balloon catheter at 60 mUmin by
means of an angiographic power injector equipped with a
warming sleeve (Angiomat 6000, Liebel-Flarsheim).
Hemodynamic measurements. Left ventricular pressure
was measured using a 3F micromanometer catheter (Millar
Instruments) inserted through a pigtail catheter positioned in
the left ventricle by means of the left femoral artery. The tip
of the pigtail catheter was situated approximately half-way
between the mid-left ventricular cavity and apical levels and
its position was checked periodically throughout the study to
ensure that it had not changed. The catheter pressure signal
was calibrated and digitized at 5 ms intervals by means of an
diastolic dysfunction during balloon inflation. Therefore, we
evaluated the effect of distal catheter infusion of Fluosol on
the dynamic changes in systolic and diastolic left ventricular
pressure variables, particularly those of ventricular relax-
ation, in patients during coronary angioplasty in a controlled
crossover study.
Methods
Patient selection. Patients with angina pectoris having
elective coronary angioplasty at the Mayo Clinic were
considered for this study. The study was approved by the
Mayo Clinic's Institutional Review Board on February 26,
1988 and informed written consent was obtained from each
patient before study.
Selection criteria for the study included I) planned coro-
nary angioplasty of ~70% stenosis (visually assessed) of the
proximal or mid-left anterior descending coronary artery,
left circumflex coronary artery or right coronary artery, with
no visible collateral flow supplying the vessel to be dilated;
and 2) normal regional wall motion in the territory of the
coronary artery to be dilated as determined by left ventric-
ulography or echocardiography. Patients were excluded
from consideration if there was I) recent acute myocardial
infarction; 2) distal vessel disease in the vessel to be dilated;
3) valvular heart disease; 4) rhythm other than sinus; and 5)
child-bearing potential.
Fifteen patients were initially enrolled in the study. Two
patients were withdrawn when it was discovered that the
vessel to be dilated had become occluded since the diagnos-
tic angiogram. A further two patients were withdrawn be-
cause of inability to cross the lesion in one and the finding of
a previously unrecognized significant left main coronary
stenosis in the other. Another patient completed the proto-
col, but the data were not analyzed because of baseline drift
of the micromanometer signal during the study. Therefore,
the study group consisted of 10 patients whose characteris-
tics appear in Table I; their mean age was 67 years. The
dilated vessels were the left anterior descending coronary
artery in eight patients, the circumflex artery in one and the
right coronary artery in one.
Study design. The study was designed as a controlled,
single-blind, randomized crossover trial with each patient
undergoing four consecutive 60 s balloon inflations. During
the first inflation, each patient was randomly assigned to
receive either distal catheter infusion of Fluosol-DA 20%
(Alpha Therapeutic) or undergo routine inflation without
infusion. After balloon deflation, 3 min were allowed before
the second inflation, at which time the patient crossed over
to receive the alternative treatment. This sequence was
repeated for the third and fourth inflations, maintaining the
same order of randomization. Thus, each patient served as
his or her own control and comparisons were made between
the inflations within each pair.
Characteristic
Mean age ± SD (yr)
Men/women
Angina (CHA class)
I
II
III
IV
Site of angioplasty (coronary artery)
Left anterior descending
Proximal
Mid
Left circumflex
Proximal
Right
Mid
Ejection fraction (9t)*
*Obtained in 6 patients. CHA = Canadian Heart Association.
67 ± 9
5/5
7
3
6
2
I
73 ± 12
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analog to digital converter and stored for later analysis.
During each inflation sequence, left ventricular pressure was
recorded at end-expiration for 5 s immediately before bal-
loon inflation, at 30 and 60 s during the inflation and at 60 s
after balloon deflation.
Off-line data analysis was performed on an IBM-AT
clone. Analysis of hemodynamic data was performed with-
out knowledge of the randomization sequence. Three to four
cardiac cycles were analyzed individually and a mean value
obtained for each measurement. The following diastolic
variables were measured: left ventricular end-diastolic pres-
sure measured at the peak of the accompanying R wave of
the electrocardiogram, minimal diastolic pressure, maximal
rate of fall in left ventricular pressure (maximal negative
dP/dt) and the time constant of ventricular relaxation (tau).
Tau was defined as the negative inverse of the slope of the
natural logarithm of pressure versus time, as originally
described by Weiss et al. (13), between the points of maxi-
mal negative dP/dt and 5 mm Hg above the previous end-
diastolic pressure. A minimum of eight sample points was
chosen for this measurement, but in one patient with a heart
rate up to 102 beats/min, such sampling could be done only
by measuring the second point at a pressure equal to the
previous end-diastolic pressure. This latter definition of tau
provides an estimation that is not significantly different from
that obtained by measuring it up to 10 mm Hg above the
previous end-diastolic pressure (I). A least squares analysis
was used to determine the best fit (r > 0.95) of the data to
this monoexponential function. Estimates of global systolic
function were peak left ventricular pressure and maximal
rate of rise in left ventricular pressure (maximal positive
dP/dt).
Angina grading. Before the study, patients were in-
structed to grade their angina on a scale of increasing
severity from 0 to 9 during the angioplasty procedure. The
time of onset and duration of any pain were recorded
throughout the procedure, as were the location, quality and
relation to previous anginal symptoms. Patients were not
aware of the order of inflations. The highest grade reported
by the patient during the period of balloon inflation was used
as an index of severity. The duration of any pain was also
recorded.
Statistical analysis. All data are expressed as mean values
± SEM unless otherwise stated. The changes from baseline
study observed at 30 and 60 s after balloon inflation and at
60 s after balloon deflation were recorded for each inflation.
To reduce the statistical problem of multiple measurements
during each inflation, individual changes from baseline val-
ues observed at 30 and 60 s were averaged. It should be
emphasized, however, that apart from peak systolic pres-
sure, no significant differences between Fluosol and control
inflations at the individual time points of 30 or 60 s were
found for any measured variable. For each patient, these
changes from baseline values were calculated for each
inflation and a comparison was made within each pair of
inflations between Fluosol and control using paired t tests,
with a significance level of alpha = 0.05.
On the basis of results of studies (8,9) showing complete
preservation by Fluosol of systolic function during coronary
occlusion, we estimated the statistical power to detect 100%
preservation of diastolic function. Using the observed stan-
dard error of the difference between Fluosol and control, we
computed the power, around the noncentral t distribution, of
rejection at the 0.05 level if the true reduction was equal to
100% of the observed change from the baseline value under
control conditions. With this approach, the estimated statis-
tical power of the measured diastolic variables was end-
diastolic pressure 85%, minimal pressure 99%, maximal
negative dP/dt 92% and tau 100%.
Results
Results of balloon inflation. Ten patients had hemody-
namic data suitable for analysis. A mean (±SD) diameter
stenosis, visually assessed, of the studied vessels of 84 ± 12%
before angioplasty was reduced to 34 ± 22% after angioplasty.
No adverse effects were noted in any patient after administra-
tion of the test dose of Fluosol nor during its intracoronary
infusion. The procedure was successful in all except one
patient, who had a severe coronary dissection during the third
inflation and required emergency coronary artery bypass sur-
gery with subsequent evidence of a non-Q wave infarction. In
this patient, the data from only the first pair of inflations were
used for analysis. In one other patient, the final inflation during
Fluosol infusion was aborted at commencement of inflation
after rupture of the balloon catheter without any clinical
sequelae. Thus, there were 18 pairs of Fluosol versus control
inflations available for comparison.
The duration of balloon inflation was 60 s for every
inflation except the final noninfusion inflation in one patient
when the balloon was deflated after 35 s because of severe
chest pain. The rest heart rate before inflations accompanied
by Fluosol infusion was 68.4 ± 3.3 beats/min compared with
70.2 ± 3.4 beats/min before control inflations (p = NS). The
heart rate after 60 s of balloon inflation during Fluosol
infusion decreased to 66.1 ± 2.8 beats/min (p = NS) and
decreased to 68.5 ± 3.3 beats/min during control inflations
(p = NS).
Hemodynamic variables (Table 2). There were no signif-
icant baseline differences before inflations with or without
Fluosol in any left ventricular diastolic or systolic variable.
During balloon inflation, there were significant increases
from preinflation values in all variables except maximal
negative dP/dt and peak systolic pressure when inflations
were accompanied by Fluosol infusion.
Diastolic variables: Fluosol versus control (Table 3). When
paired Fluosol and control inflations were analyzed, no
significant differences were observed for the changes from
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Table 2. Hemodynamic Changes From Baseline (before inflation) During 60 s Balloon
Inflations (n = 18)
Inflation
Hemodynamic Fluosolor (mean of 30 and
Measurement Control Baseline 60 s) p Value
Diastole
LVEDP (mm Hg) F 26.0 :!: 2.6 31.1 :!: 2.2 0.005
C 27.4 :!: 2.0' 33.2:!:2.1 0.001
Minimal pressure F 15.3 :!: 1.9 20.8:!: 1.8 0.001
(mm Hg) C 16.0:!: 1.6' 21.2 :!: 1.8 <0.001
Maximal negative F 1.446 :!: 79 1.334 :!: 69 0.055
dP/dt (mm Hg/s) C 1.501 :!: 80' 1.250:!: 68 0.001
Tau (ms) F 51.2 :!: 2.7 61.7 :!: 4.0 <0.001
C 51.3 :!: 2.6' 64.8 :!: 4.2 0.002
Systole
Peak pressure F 144.4 :!: 7.1 143.0 :!: 6.7 0.523
(mm Hg) C 148.2 :!: 8.2' 137.7 :!: 6.3 0.018
Maximal positive dP/dt F 1.548 :!: 68 1.380 :!: 69 <0.001
(mm Hglsl C 1.586 :!: 62' 1.301 :!: 67 <0.001
'p = not significant (Fluosol versus controll. C = control: F = Fluosol: LVEDP = left ventricular end-diastolic
pressure: Maximal negative dP/dt = maximal rate offaU in pressure: Maximal positive dP/dt = maximal rate of rise
in pressure: Tau =time constant of ventricular relaxation.
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baseline study to inflation in either end-diastolic pressure.
tau, maximal negative dP/dt or minimal diastolic pressure.
Individual comparisons for each inflation (n = 18) are
illustrated in Figure I. A small difference in favor of Fluosol
over control was noted for maximal negative dP/dt, but this
did not reach statistical significance. There were also no
significant differences between the two groups with respect
to the change between baseline and recovery at 60 s after
deflation in any of these 'variables (Fig. 2).
Table 3. Comparison Between Control and Fluosol Inflations of
the Change in Each Hemodynamic Variable From Baseline to
Inflation and From Baseline to Recovery After Deflation
Difference Between Control and Fluosol
Changes From Baseline
During After
Inflation p Deflation p
Measurement (n = 18) Value (n = 18) Value
Diastole
LVEDP (mm Hg) +0.7 :!: 1.8 0.719 -1.7:!:2.0 0.388
Minimal pressure -0.3:!: 1.4 0.816 -0.9:!: 1.5 0.544
(mm Hg)
Maximal negative -133:!:70 0.060 -15 :!: 69 0.831
dP/dt (mm Hgls)
Tau (ms) +2.9:!: 2.4 0.231 -2.9 :!: 2.9 0.325
Systole
Peak pressure -9.0 :!: 3.3 0.013 -5.9 :!: 3.8 0.132
(mm Hg)
Maximal positive dP/dt -120:!:65 0.081 -5 :!: 66 0.935
(mm Hg/sl
Abbreviations as in Table 2.
Systolic variables: Fluosol versus control (Table 3). Paired
comparison between inflations with or without accompany-
ing Fluosol infusion revealed a small but significant differ-
ence in the change from baseline peak systolic pressure (Fig.
3A). During control inflations. systolic pressure decreased
more compared with Fluosol inflations (-9.0 ± 3.3 mm Hg.
p = 0.013). However. no significant difference was observed
in the changes in maximal positive dP/dt (Fig. 3B). No
significant differences were noted between the two types of
inflations in either of these two variables at 60 s after
deflation (Fig. 4).
Angina during coronary angioplasty. Anginal pain re-
ported by patients was significantly less during balloon
inflations accompanied by Fluosol infusion than inflations
without. The reported peak intensity in patients during
Fluosol inflations was 2.7 ± 0.6 versus 4.4 ± 0.8 during
control inflations (p < 0.001). The average duration of pain
was similar (41 ± 16 s during Fluosol inflations and 46 ±
13 s during control inflations, p = NS).
Discussion
Previous studies (1.2.10-12) have demonstrated that global
diastolic dysfunction is usually an earlier and more sensitive
marker for myocardial ischemia than changes in global
systolic function. Hemodynamic studies (1,3) during coro-
nary artery balloon occlusion have demonstrated that the
time constant of ventricular relaxation (tau), left ventricular
end-diastolic pressure and minimal pressure all increase and
that peak left ventricular pressure and maximal positive and
lACC Vol. 16. No.4
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Figure 1. Paired comparison between Fluosol and control inflations
in the change from baseline measurements to inflation of the diastolic
variables. A, Left ventricular end-diastolic pressure. B, Minimal dias-
tolic pressure. C, Maximal rate of fall in pressure (maximal negative
dP/dt). D, Time constant of ventricular relaxation (tau).
Figure 2. Paired comparison between Fluosol and control inflations in
the change from baseline measurements to recovery (60 s after defla-
tion) of the diastolic variables. A, Left ventricular end-diastolic pres-
sure. B, Minimal diastolic pressure. C, Maximal rate offall in pressure
(maximal negative dP/dt). D, Time constant of ventricular relaxation
(tau).
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Figure 3. Paired comparison between Fluosol and control inflations
in the change from baseline measurements to inflation of the systolic
variables. A, Peak left ventricular systolic pressure. H, Maximal rate
of rise in pressure (positive dP/dt).
Figure 4. Paired comparison between Fluosol and control inflations
in the change from baseline measurements to recovery (60 s after
deflation) of the systolic variables. A, Peak left ventricular systolic
pressure. B, Maximal rate of rise in pressure (positive dP/dl).
negative dP/dt decrease. In addition, Serruys et al. (I) have
shown that the relaxation variables during early diastole. tau
and maximal negative dP/dt precede changes in left ventric-
ular end-diastolic pressure and the hemodynamic variables
of systolic function. Therefore, these diastolic variables may
more accurately reflect the efficacy of myocardial protection
techniques during coronary angioplasty than do other more
frequently used measurements.
Present study. In this study. we found that. as expected.
there were significant changes during the control coronary
balloon inflations in all of the measured variables. Distal
catheter infusion of Fluosol during coronary angioplasty
reduced the degree of angina experienced by patients and
prevented any significant decrease in peak systolic pressure.
but the benefit over control inflations appeared small. Com-
pared with control inflations. the changes observed during
balloon inflation with Fluosol in end-diastolic pressure,
minimal diastolic pressure, tau and maximal negative dP/dt
were not significantly different. Similarly, there were no
differences between the two types of inflation with respect to
the recovery of these variables at I min after balloon
deflation.
Clinical relevance. If any method of myocardial protec-
tion is to be clinically useful (for example. in allowing
prolonged balloon inflations or performing coronary angio-
plasty in high risk patients with limited ventricular contrac-
tile reserve). it should be capable of completely or almost
completely preventing ischemia and left ventricular dysfunc-
tion. Global responses (for example, in left ventricular
end-diastolic pressure) are relevant to the acute management
of the patient during angioplasty. Prolongation of ventricular
relaxation and abnormally elevated diastolic pressures will
adversely affect coronary perfusion, wall stress and pulmo-
nary venous emptying. Therefore. because our results sug-
gest that the effect of Fluosol during 60 s of coronary
occlusion with balloon inflation appears minimal in patients
with relatively normal left ventricular function. its efficacy in
patients with preexisting ventricular dysfunction could be
limited. However. this needs to be studied carefully using
both echocardiographic and hemodynamic measurements.
Previous studies. Animal studies. Virmani et al. (14)
showed no significant difference in left ventricular pressure,
heart rate or maximal positive dP/dt in dogs during eight
90 s balloon inflations with or without Fluosol infusion. They
also found ultrastructural changes on electron microscopy
consistent with myocardial ischemia in animals treated with
Fluosol, suggesting that prevention of ischemia was not
complete. In a canine study of 2 min coronary balloon
lACC Vol. 16, No, 4
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inflations with or without distal Fluosol infusion. Tokioka et
aL (15) demonstrated only partial improvement of regional
and global myocardial function with Fluosol compared with
control, Fluosol did not prevent the production of lactate or
the development of ST segment elevation on the electrocar-
diogram and only catheter perfusion of arterial blood offered
complete myocardial protection in this same study,
In another canine study comparing Fluosol and autolo-
gous blood as coronary perfusion agents during ischemia,
Christensen et aL (16) found that Fluosol induced a signifi-
cant decrease in diastolic coronary pressure and resistance.
They also observed that there was a relative decrease in
subendocardial blood flow, with a significant reduction in the
amount of oxygen delivery to this region, In contrast.
autologous blood was able to maintain normal flow and
oxygen delivery.
Human studies. Clinical studies examining the efficacy of
Fluosol infusion during coronary angioplasty with respect to
left ventricular performance have generally employed quan-
titative echocardiographic techniques. These studies indi-
cated that Fluosol completely prevented regional wall mo-
tion abnormalities (8) and preserved global ejection fraction
(9). However, because hemodynamic variables were not
measured in either study. direct comparison with the present
study is not possible.
Despite the results of these studies, possible method-
ologic problems should be considered. The method of mea-
suring chord shortening to quantify regional wall motion
used in the first study (8) was originally described for
analysis of contrast ventriculograms; in addition to its own
limitations (17), it may not necessarily be applicable to
conventional echocardiography with its inherent limitations
of suboptimal spatial resolution and noise, patient motion
and the requirement that the imaging plane remain constant
throughout the 60 to 90 s of balloon inflation. Problems in
quantifying echocardiographic images have also been de-
scribed previously (18).
Apparent improvement in diastolic function. using Dopp-
ler-derived indexes of mitral flow velocity. during angio-
plasty accompanied by Fluosol infusion was described in
preliminary form from the same group (19). However. recent
studies (20-22) concerned with the hemodynamic validation
of current Doppler indexes of diastolic function have
stressed important limitations in the interpretation of some
of these indexes.
Diastolic versus systolic dysfunction. Although coronary
perfusion with Fluosol may preserve regional (8) as well as
global (9) systolic function, our results suggest that it does
not preserve global diastolic function. It is possible that
systolic function was also preserved in our study as indi-
cated by the effect on peak systolic pressure. although no
beneficial effect on maximal positive dP/dt was observed.
One possible explanation for these disparate findings may be
that Fluosol is a relative volume expander. Although this
property of Fluosol could favorably influence both regional
and global systolic function, it may adversely influence
ventricular relaxation. However, it should be realized that
sudden volume expansion is unlikely to be well tolerated by
patients with severe left ventricular dysfunction.
An alternative explanation is that despite the potential to
preserve regional and global systolic function, Fluosol is
unable to preserve global diastolic function. Dissociation
between systolic and diastolic measurements of ventricular
dysfunction has been documented in various cardiac dis-
eases including ischemia (10-12). This could be explained by
the greater vulnerability of diastolic function to ischemia
compared with systolic function (10,23) and the inability of
Fluosol to completely prevent myocardial ischemia (15,16).
Oxygen delivery. The inability of Fluosol to completely
prevent myocardial ischemia may be related to its inferior
oxygen delivery to the myocardium relative to that of arterial
blood. Normal coronary blood flow at rest (for example, in
the left anterior descending artery) varies among individuals,
but an average flow of 80 ml/min is assumed. Normal
myocardial oxygen extraction in the left ventricle is much
higher than for most other organs and is approximately 12
vol% (24). which is extracted from arterial blood with an
oxygen content of 17 to 18 vol%. The oxygen content of 6
vol% (25) for Fluosol, coupled with its delivery rate of 60
ml/min indicate that it is capable of delivering only about one
third the volume of oxygen to the left ventricle compared
with normal arterial blood. One method to overcome this
would be to infuse Fluosol at a higher rate, but this could
present some technical problems.
Furthermore, during manipulation of the balloon cathe-
ter. severe ischemia may result because of subtotal occlu-
sion by the deflated balloon at the site of a severe stenosis
(we actually observed an increase in left ventricular end-
diastolic pressure in most patients during the positioning of
the balloon). The normal response of the coronary circula-
tion after relief of this obstruction is to increase coronary
flow briefly to about four to six times that of the flow at rest.
the so-called hyperemic response. "Relief" of this occlusion
in this study was obtained at the time of balloon inflation
with perfusion of Fluosol. but as discussed, the relatively
inefficient delivery of oxygen would, at least initially, be
unable to meet the demands of the ischemic myocardium.
Limitations of study. When interpreting the results of this
study, there are potentially important limitations to con-
sider. A relatively small number of patients were studied.
Also, although there were no differences among diastolic
variables to favor Fluosol. a small possibility of a type II
error is acknowledged. However, in our study there was
sufficient power (85% to 100%) to detect complete preserva-
tion of these variables, which was the same magnitude of
effect on systolic function observed in previous studies (8,9).
Re{?ional rentrieular function was flot assessed in this
study and our measurements were probably insensitive to
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changes in regional diastolic function. In comparing infusion
of Fluosol with "no infusion." it is possible that despite the
low viscosity of Fluosol the hydraulic effect of infusion
through the coronary arteries altered the diastolic properties
of the ventricular wall. although the effects of this would
appear to be the same as ischemia alone. However. because
patients did experience chest pain of similar duration during
Fluosol infusion, although less severe. these findings are
most likely secondary to ischemia.
Finally, there are also some possible limitations to con-
sider in the measurements used in our study. Tau can be
computed for a number of mathematic models of pressure
decay, but may not always reflect true ventricular relax-
ation, although the mathematic model for describing tau
used in this study appears to more closely reflect the known
physiology (26).
Conclusion. Distal catheter infusion of Fluosol during
coronary angioplasty does not preserve global diastolic
function and specifically does not prevent abnormal ventric-
ular relaxation. This raises the possibility that Fluosol may
be sufficient to lessen systolic but not global diastolic dete-
rioration of function during coronary occlusion. Future
studies should address this possibility.
We thank Steven Winter and Kristina Menke. RN for their technical expertise
and assistance. Fluosol-DA 20% was supplied by Alpha Therapeutic Corpo-
ration. Los Angeles. California.
References
1. Serruys PW. Wijns W. van den Brand M. et al. Left ventricular perfor-
mance, regional blood flow. wall motion. and lactate metabolism during
transluminal angioplasty. Circulation 1984:70:25-36.
2. Labovitz AJ. Lewen MK. Kern M. et al. Evaluation of left ventricular
systolic and diastolic dysfunction during transient myocardial ischemia
produced by angioplasty. J Am Coil Cardiol 1987:10:748-55.
3. Bertrand ME, Lablanche JM. Fourrier JL. Traisnel G. Mirsky 1. Left
ventricular systolic and diastolic function during acute coronary artery
balloon occlusion in humans. J Am Coil Cardiol 1988:12:341-7.
4. Wijns W. Serruys PW. Slager CJ. et al. Effects of coronary occlusion
during percutaneous transluminal angioplasty in humans on left ventric-
ular chamber stiffness and regional diastolic pressure-radius relations.
J Am Coil Cardiol 1986:7:455-63.
5. Visser CA. David GK. Kan G. et al. Two-dimensional echocardiography
during percutaneous transluminal coronary angioplasty. Am Heart J
1986:111: 1035-41.
6. Quigley PJ. Kereiakes DJ. Hinohara T. et al. Efficacy of gradual.
prolonged balloon inflation during coronary angioplasty in humans using
an autoperfusion catheter (abstrl. Circulation 1988:78(suppl /l):1l-449.
7. Anderson HV. Leimgruber PP. Roubin GS. Nelson DL. Gruentzig AR.
Distal coronary artery perfusion during percutaneous transluminal coro-
nary angioplasty. Am Heart J 1985:110:720-6.
8. Cleman M, Jaffe Ce. Wohlgelernter D. Prevention of ischemia during
percutaneous transluminal coronary angioplasty by transcatheter infusion
of oxygenated Fluosol DA 20%. Circulation 1986:74:555-62.
9. Jaffe Cc. Wohlgelernter D. Cabin H. et al. Preservation of left ventricular
ejection fraction during percutaneous transluminal coronary angioplasty
by distal transcatheter coronary perfusion of oxygenated Fluosol DA
20%. Am Heart J 1988:115:1156-64.
10. Aroesty JM. McKay RG. Heller GV. Royal HD. Als AV. Grossman W.
Simultaneous assessment of left ventricular systolic and diastolic dys-
function during pacing-induced ischemia. Circulation 1985:71:889-900.
II. Smalling RW. Kelley KO. Kirkeeide RL. Gould KL. Comparison of early
systolic and early diastolic regional function during regional ischemia in a
chronically instrumented canine model. J Am Coli Cardiol 1983:2:263-9.
12. Bonow RO. Bacharach SL. Green MY. et al. Impaired left ventricular
diastolic filling in patients with coronary artery disease: assessment with
radionuclide angiography. Circulation 1981 :64:315-23.
13. Weiss JL. Frederiksen JW. Weisfeldt ML. Hemodynamic determinants of
the time-course of fall in canine left ventricular pressure. J Clin Invest
1976:58:751-60.
14. Virmani R. Kolodgie FD. Osmialowski A. Zimmerman P. Mergner W.
Forman MB. Myocardial protection by perfluorochemical infusion during
transient ischemia produced by balloon coronary occlusion. Am Heart J
1988:116:421-31.
15. Tokioka H. Miyazaki A. Fung P. et al. Effects of intracoronary infusion
of arterial blood or Fluosol-DA 20% on regional myocardial metabolism
and function during brief coronary artery occlusions. Circulation 1987:75:
473-81.
16. Christensen CWo Reeves We. Lassar TA. Schmidt DH. Inadequate
subendocardial oxygen delivery during perfluorocarbon perfusion in a
canine model of ischemia. Am Heart J 1988:115:30-7.
17. Sheehan FH. Stewart DK. Dodge HT. Mitten S. Bolson EL. Brown BG.
Variability in the measurement of regional left ventricular wall motion
from contrast angiograms. Circulation 1983:68:550-9.
18. Sandor T. Henschke C. Risser TA. Hanlon WB. Neumann A. Wynne J.
Quantitative analysis of left ventricular wall motion and thickness using
two-dimensional echocardiography. Int J Biomed Comput 1983:14:431-9.
19. Bowman L. Cleman M. Cabin H. Hasselman S, Jaffe Cc. Preservation of
diastolic function and cardiac output during PTCA with distal coronary
perfusion of Fluosol-DA 20% (abstr). J Am Coil Cardiol 1988:ll(suppl
A):133A.
20. Courtois M. Kovacs 5J. Ludbrook PA, Transmitral pressure·flow veloc-
ity relation: importance of regional pressure gradients in the left ventricle
during diastole. Circulation 1988:78:661-71.
21. Choong CY. Abascal VM. Thomas JD. Guerrero JL. McGlew S. Weyman
AE. Combined influence of ventricular loading and relaxation on the
transmitral flow velocity profile in dogs measured by Doppler echocar-
diography. Circulation 1988:78:672-83.
22. Courtois M. Vered Z. Barzilai B. Ricciotti NA. Perez JE. Ludbrook PA,
The transmitral pressure-flow velocity relation: effect of abrupt preload
reduction. Circulation 1988:78: 1459-68.
23. SI. John Sutton MG. Ritman EL. Paradise NF. Biphasic changes in
maximum relaxation rate during progressive hypoxia in isometric kitten
papillary muscle and isovolumic rabbit ventricle. Circ Res 1980;47:
516-24.
24. Bing RJ. The coronary circulation in health and disease as studied by
coronary sinus catheterization. Bull N Y Acad Med 1951:27:407-24.
25. Tremper KK. Friedman AE. Levine EM. Lapin R. Camarillo D. The
preoperative treatment of severely anemic patients with a perfluorochem-
ical oxygen-transport fluid. Fluosol-DA. N Engl 1 Med 1982:307:277-83.
26. Mirsky I. Assessment of diastolic function: suggested methods and future
considerations. Circulation 1984:69:836-41.
